Skip to content

Clinical trials

Phase 1/2 Hereditary Sensory and Autonomic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 1/2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20103
20121
20132
20161
20171
20202
20213
20222
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting8
Active, not recruiting2
Terminated2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati3
Cascadian Therapeutics Inc.2
Novartis Pharmaceuticals2
Acrivon Therapeutics1
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
Artios Pharma Ltd1
Arvinas Inc.1
Curis, Inc.1
David Bajor, MD1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies25
Breast Neoplasms5
Colorectal Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Non-Small-Cell Lung4
Ovarian Neoplasms4
Recurrence4
Endometrial Neoplasms3
Head and Neck Neoplasms3
Tuberous Sclerosis3

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.